Real-Time Continuous Glucose Monitoring Lowers Risk of Large for Gestational Age Infants in Gestational Diabetes
Real-time continuous glucose monitoring significantly enhances glycemic control in gestational diabetes, reducing risks for large newborns compared to traditional methods.
Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes
EASD 2025: The risk of developing the 4 primary subtypes of T2D was increased by as much as 3-fold and was not dependent on duration of smoking behavior.
FDA Approves Automated Insulin Delivery System for Adults With T2D: Daily Dose
Your daily dose of the clinical news you may have missed.
Most Parents Trust Standard Childhood Vaccines, But Question Flu and COVID-19 Shots: KFF-Washington Post Survey
Most parents support childhood vaccines like MMR and polio, but skepticism about seasonal and newer shots persists along with distrust of federal agencies.
US States Ranked Lowest on 9 Essential Vaccination Indicators
States in the deep South and the West consistently ranked lowest on rates of flu vaccination across age groups, number of teens vaccinated against HPV, and older individuals with shingles vaccination.
Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis
A single dose of neffy was effective in nearly 90% of patients treated for anaphylactic reactions during oral food challenge and allergen immunotherapy.
Family Physician to Colleagues: Please, Value Your Own Mental Health
Teresa Lovins, MD, talked with Patient Care about suicidal ideation among patients and then focused on asking her colleagues to make their own mental health a priority.
Implementing HPV Self-Collection Tests in Primary Care: A Discussion with Ada Stewart, MD
Ada Stewart, MD, board-certified family physician, offers strategies for introducing HPV self-collection tests, addressing patient communication, follow-up challenges, and more.
Duration of Use Guidance Published for Systemic Corticosteroids in Atopic Dermatitis Treatment
The new position paper faults the absence of a clearly defined, evidence-based ceiling on duration of use for the persistent overuse of systemic corticosteroids for AD management.
Rideshare Program Could Improve Colonoscopy Completion and Reduce CRC Burden, Study Finds
A new modeling study suggests rideshare programs could double colonoscopy completion after abnormal FIT results, cutting colorectal cancer incidence and deaths while saving health care costs.
New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse
Opioids are still prescribed to 1 in 5 US adults with chronic pain because effective alternatives are not available; the FDA guidance supports enhanced research paradigms.
Subcutaneous Leqembi Autoinjector Gains FDA Approval for Maintenance Use in Early Alzheimer Disease: Daily Dose
Family Physician Teresa Lovins, MD, Says A Simple Phone Call Could Save a Life
The phone call can be short, but the outreach and contact are key after a patient with suicidal ideation is referred for emergency or inpatient support, Lovins says.
HPV Self-Collection: A New Tool for Cervical Cancer Screening in Primary Care
Ada Stewart, MD, discusses how HPV self-collection tests can expand cervical cancer screening options in primary care while addressing patient barriers and limitations.
Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data
Once-daily blarcamesine was associated with minimal cognitive decline at 48 weeks, with changes comparable to those observed in prodromal aging.
Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents
Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.
New Data Shows Risk of Major Depressive Disorder Spikes After a Medical Diagnosis: Daily Dose
OX40 Antagonist Amlitelimab Meets All Primary and Secondary Endpoints in Phase 3 Atopic Dermatitis Trial
Sanofi's amlitelimab, dosed every 4 or 12 weeks, was superior to placebo in efficacy and skin clearance, with efficacy increasing throughout the treatment period.
How to Address Patient Hesitancy Around Cervical Cancer Screening With Ada Stewart, MD
Ada Stewart, MD, shares strategies for primary care physicians to reduce patient anxiety and improve comfort during cervical cancer screening exams.
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis
Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.